FOLLOW US

  • facebook
  • twitter
Fri

March 20, 2026

Gilead to acquire Arcellx

America February 23, 2026

Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy

In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…

By Rihem Akkouche

AbbVie $2B Licensing Agreement

America July 10, 2025

AbbVie Strikes $2B Licensing Deal with IGI Therapeutics

In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter